Literature DB >> 22798248

Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer?

Saila Kauhanen, Camilla Schalin-Jäntti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798248     DOI: 10.1007/s12020-012-9740-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  15 in total

1.  Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.

Authors:  Saila Kauhanen; Camilla Schalin-Jäntti; Marko Seppänen; Sami Kajander; Sami Virtanen; Jukka Schildt; Irina Lisinen; Aapo Ahonen; Ilkka Heiskanen; Mika Väisänen; Johanna Arola; Pirkko Korsoff; Tapani Ebeling; Timo Sane; Heikki Minn; Matti J Välimäki; Pirjo Nuutila
Journal:  J Nucl Med       Date:  2011-11-03       Impact factor: 10.057

2.  Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.

Authors:  J C Reubi; J C Schaer; B Waser; G Mengod
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

3.  2012 European thyroid association guidelines for metastatic medullary thyroid cancer.

Authors:  M Schlumberger; L Bastholt; H Dralle; B Jarzab; F Pacini; J W A Smit
Journal:  Eur Thyroid J       Date:  2012-03-28

4.  Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.

Authors:  Brendon G Conry; Nikolaos D Papathanasiou; Vineet Prakash; Irfan Kayani; Martyn Caplin; Shahid Mahmood; Jamshed B Bomanji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

5.  Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.

Authors:  Giorgio Treglia; Paola Castaldi; Maria Felicia Villani; Germano Perotti; Chiara de Waure; Angelina Filice; Valentina Ambrosini; Nadia Cremonini; Monica Santimaria; Annibale Versari; Stefano Fanti; Alessandro Giordano; Vittoria Rufini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-06       Impact factor: 9.236

Review 6.  Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis.

Authors:  Giorgio Treglia; Maria Felicia Villani; Alessandro Giordano; Vittoria Rufini
Journal:  Endocrine       Date:  2012-04-17       Impact factor: 3.633

7.  Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.

Authors:  Anne Laure Giraudet; Daniel Vanel; Sophie Leboulleux; Anne Aupérin; Clarisse Dromain; Linda Chami; Noël Ny Tovo; Jean Lumbroso; Nathalie Lassau; Guillaume Bonniaud; Dana Hartl; Jean-Paul Travagli; Eric Baudin; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2007-08-28       Impact factor: 5.958

8.  18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.

Authors:  Klaas P Koopmans; Jan Willem B de Groot; John T M Plukker; Elisabeth G E de Vries; Ido P Kema; Wim J Sluiter; Pieter L Jager; Thera P Links
Journal:  J Nucl Med       Date:  2008-04       Impact factor: 10.057

9.  Correlation between Calcitonin Levels and [(18)F]FDG-PET/CT in the Detection of Recurrence in Patients with Sporadic and Hereditary Medullary Thyroid Cancer.

Authors:  Evangelia Skoura; Ioannis E Datseris; Phivi Rondogianni; Stylianos Tsagarakis; Marinella Tzanela; Maria Skilakaki; Dimitrios Exarhos; Maria Alevizaki
Journal:  ISRN Endocrinol       Date:  2012-05-10

10.  Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging.

Authors:  G Pellegriti; S Leboulleux; E Baudin; N Bellon; C Scollo; J P Travagli; M Schlumberger
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

View more
  1 in total

1.  F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value.

Authors:  Francesco Bertagna; Giorgio Treglia; Arnoldo Piccardo; Elisabetta Giovannini; Giovanni Bosio; Giorgio Biasiotto; El Khayat Bahij; Roberto Maroldi; Raffaele Giubbini
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.